Survival Among Patients Treated with Total Mesorectal Excision or Selective Watch-and-Wait After Total Neoadjuvant Therapy: A Pooled Analysis of the CAO/ARO/AIO-12 and OPRA Randomized Phase II Trials.
Williams H, Fokas E, Diefenhardt M, Lee C, Verheij FS, Omer DM, Lin ST, Dunne RF, Marcet J, Cataldo P, Polite B, Piso P, Polat B, Dapper H, Ghadimi M, Hofheinz RD, Qin LX, Saltz LB, Wu AJ, Gollub MJ, Smith JJ, Weiser MR, Rödel C, Garcia-Aguilar J; German Rectal Cancer Study Group; OPRA Consortium.
Williams H, et al. Among authors: wu aj.
Ann Oncol. 2025 Jan 21:S0923-7534(25)00010-9. doi: 10.1016/j.annonc.2025.01.006. Online ahead of print.
Ann Oncol. 2025.
PMID: 39848335